The quetiapine fumarate extended-release tablets are sold under the brand name Seroquel XR by AstraZeneca Pharmaceuticals. This represents Biovail’s third successful abbreviated new drug application (ANDA) filing in 2008.
Seroquel XR is an atypical antipsychotic agent indicated for the treatment of schizophrenia and bipolar disorder. The product is available in 150mg, 200mg, 300mg and 400mg strengths.